A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer
Background and purpose: In uterine cervical cancer tumour spread reaching the para-aortic lymph nodes is the most significant independent pre-treatment predictor of progression-free survival. When introducing [18F]fluorodeoxyglucose-positron emission tomography (FDG-PET)/computed tomography (CT) in...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-10-01
|
Series: | Physics and Imaging in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405631618300617 |
id |
doaj-2f8e91d4e43a4509ba11cc8d935a2093 |
---|---|
record_format |
Article |
spelling |
doaj-2f8e91d4e43a4509ba11cc8d935a20932020-11-25T00:41:12ZengElsevierPhysics and Imaging in Radiation Oncology2405-63162018-10-0183337A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancerAnn-Charlotte Waldenström0Karin Bergmark1Annika Michanek2Farida Hashimi3Rauni Rossi Norrlund4Caroline E. Olsson5Peter Gjertsson6Henrik Leonhardt7Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sweden; Corresponding author at: Regional Cancer Center West, Medicinaregatan 18 G, SE 41345 Göteborg, Sweden.Department of Oncology, Sahlgrenska University Hospital, SwedenDepartment of Nuclear Medicine, Sahlgrenska University Hospital, SwedenDepartment of Radiology, Sahlgrenska University Hospital, SwedenDepartment of Radiology, Sahlgrenska University Hospital, SwedenDepartment of Radiation Physics, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sweden; Regional Cancer Center West, The Western Sweden Healthcare Region, Gothenburg, SwedenDepartment of Nuclear Medicine, Sahlgrenska University Hospital, SwedenDepartment of Radiology, Sahlgrenska University Hospital, SwedenBackground and purpose: In uterine cervical cancer tumour spread reaching the para-aortic lymph nodes is the most significant independent pre-treatment predictor of progression-free survival. When introducing [18F]fluorodeoxyglucose-positron emission tomography (FDG-PET)/computed tomography (CT) in our clinic for patients with advanced cervical cancer planned for definitive radiochemotherapy, the purpose of this study was to quantify to what extent the added information lead to changes in radiotherapy planning. Material and methods: We included 25 consecutive patients with cervical cancer stages IB2 – IIIB planned for definitive radiochemotherapy between November 2010 and May 2012. The patients were examined both with magnetic resonance imaging (MRI) and FDG-PET/CT before treatment and after four weeks of treatment. Results: In 11/24 (46%) of the patients the FDG-PET/CT before treatment provided additional diagnostic information leading to changes in treatment planning compared to information from MRI. Seven of these eleven patients (64%) were alive and without evidence of disease at four-year follow-up. The MRI detected pelvic tumour spread not seen on the FDG-PET/CT in 2/24 patients. The disease-free four-year survival was 59%. Conclusions: Additional diagnostic information from FDG-PET/CT changed treatment strategy in almost half of the patients and may have increased chances of survival in this limited group of patients with locally advanced uterine cervical cancer. We recommend both modalities for nodal detection. Keywords: Cervical cancer, Nodal spread, Radiochemotherapy, FDG-PET/CT, MRIhttp://www.sciencedirect.com/science/article/pii/S2405631618300617 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ann-Charlotte Waldenström Karin Bergmark Annika Michanek Farida Hashimi Rauni Rossi Norrlund Caroline E. Olsson Peter Gjertsson Henrik Leonhardt |
spellingShingle |
Ann-Charlotte Waldenström Karin Bergmark Annika Michanek Farida Hashimi Rauni Rossi Norrlund Caroline E. Olsson Peter Gjertsson Henrik Leonhardt A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer Physics and Imaging in Radiation Oncology |
author_facet |
Ann-Charlotte Waldenström Karin Bergmark Annika Michanek Farida Hashimi Rauni Rossi Norrlund Caroline E. Olsson Peter Gjertsson Henrik Leonhardt |
author_sort |
Ann-Charlotte Waldenström |
title |
A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer |
title_short |
A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer |
title_full |
A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer |
title_fullStr |
A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer |
title_full_unstemmed |
A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer |
title_sort |
comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer |
publisher |
Elsevier |
series |
Physics and Imaging in Radiation Oncology |
issn |
2405-6316 |
publishDate |
2018-10-01 |
description |
Background and purpose: In uterine cervical cancer tumour spread reaching the para-aortic lymph nodes is the most significant independent pre-treatment predictor of progression-free survival. When introducing [18F]fluorodeoxyglucose-positron emission tomography (FDG-PET)/computed tomography (CT) in our clinic for patients with advanced cervical cancer planned for definitive radiochemotherapy, the purpose of this study was to quantify to what extent the added information lead to changes in radiotherapy planning. Material and methods: We included 25 consecutive patients with cervical cancer stages IB2 – IIIB planned for definitive radiochemotherapy between November 2010 and May 2012. The patients were examined both with magnetic resonance imaging (MRI) and FDG-PET/CT before treatment and after four weeks of treatment. Results: In 11/24 (46%) of the patients the FDG-PET/CT before treatment provided additional diagnostic information leading to changes in treatment planning compared to information from MRI. Seven of these eleven patients (64%) were alive and without evidence of disease at four-year follow-up. The MRI detected pelvic tumour spread not seen on the FDG-PET/CT in 2/24 patients. The disease-free four-year survival was 59%. Conclusions: Additional diagnostic information from FDG-PET/CT changed treatment strategy in almost half of the patients and may have increased chances of survival in this limited group of patients with locally advanced uterine cervical cancer. We recommend both modalities for nodal detection. Keywords: Cervical cancer, Nodal spread, Radiochemotherapy, FDG-PET/CT, MRI |
url |
http://www.sciencedirect.com/science/article/pii/S2405631618300617 |
work_keys_str_mv |
AT anncharlottewaldenstrom acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT karinbergmark acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT annikamichanek acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT faridahashimi acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT raunirossinorrlund acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT carolineeolsson acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT petergjertsson acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT henrikleonhardt acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT anncharlottewaldenstrom comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT karinbergmark comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT annikamichanek comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT faridahashimi comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT raunirossinorrlund comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT carolineeolsson comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT petergjertsson comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer AT henrikleonhardt comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer |
_version_ |
1725286750156226560 |